SAN DIEGO--(BUSINESS WIRE)--Forward Ventures announced today that it has joined the financing syndicate for Altair Therapeutics, Inc., a new venture capital-funded biotechnology company created to focus on the discovery, development and commercialization of antisense drugs to treat asthma and other respiratory conditions.
